Selected studies of auto-HCT in relapsed follicular lymphoma
| Study . | Design . | Patients, n . | PFS, % (follow-up, y) . | OS, % (follow-up, y) . |
|---|---|---|---|---|
| “CUP” Trial; Schouten et al15 | Prospective randomized | 65 | 55-58 (2) | 71-77 (4) |
| NCCN Lymphoma Outcomes; Evens et al28 | Multicenter | 135 | 57 (3) | 87 (3) |
| CIBMTR; Kluchnikov et al46 | Registry | 250 | 41 (5) | 74 (5) |
| CIBMTR; Kluchnikov et al47 | Registry | 136 | 36 (5) | 59 (5) |
| EBMT Lymphoma Working Party; Robinson et al48 | Registry | 726 | 48 (5) | 72 (5) |
| Study . | Design . | Patients, n . | PFS, % (follow-up, y) . | OS, % (follow-up, y) . |
|---|---|---|---|---|
| “CUP” Trial; Schouten et al15 | Prospective randomized | 65 | 55-58 (2) | 71-77 (4) |
| NCCN Lymphoma Outcomes; Evens et al28 | Multicenter | 135 | 57 (3) | 87 (3) |
| CIBMTR; Kluchnikov et al46 | Registry | 250 | 41 (5) | 74 (5) |
| CIBMTR; Kluchnikov et al47 | Registry | 136 | 36 (5) | 59 (5) |
| EBMT Lymphoma Working Party; Robinson et al48 | Registry | 726 | 48 (5) | 72 (5) |
CIBMTR, Center for International Blood and Marrow Transplant Research; EBMT, European Society for Blood and Marrow Transplantation; NCCN, National Cancer Care Network.